ALBHF (Alibaba Health Information Technology) 14-Day RSI : 53.24 (As of Dec. 13, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Alibaba Health Information Technology 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-13), Alibaba Health Information Technology's 14-Day RSI is 53.24.

The industry rank for Alibaba Health Information Technology's 14-Day RSI or its related term are showing as below:

ALBHF's 14-Day RSI is ranked worse than
53.6% of 709 companies
in the Healthcare Providers & Services industry
Industry Median: 48.73 vs ALBHF: 53.24

Competitive Comparison of Alibaba Health Information Technology's 14-Day RSI

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alibaba Health Information Technology's 14-Day RSI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's 14-Day RSI falls into.

Alibaba Health Information Technology (OTCPK:ALBHF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI

100

–

[ 100

( 1 + Average Gain

Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology (OTCPK:ALBHF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

Alibaba Health Information Technology 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.

Alibaba Health Information Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (OTCPK:ALBHF) » Definitions » 14-Day RSI

Traded in Other Exchanges

ALBBY:USA 00241:Hong Kong TWY:Germany

Address

Guanghua Road, 65th Floor, CITIC Tower, Building 1, No.10 Courtyard, Jianwai Subdistrict, Chaoyang District, Beijing, CHN

Website

https://www.alihealth.cn

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.